3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Ganglioneuroblastoma
2
Recurrence
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Rituximab
9
ibrutinib
6
acalabrutinib
6
Cyclophosphamide
6
zanubrutinib
4
venetoclax
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Methotrexate
3
Magnetic Resonance Spectroscopy
3
Cytarabine
3
Cyclosporine
3
CT-P10
3
Bendamustine Hydrochloride
3
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Etoposide
2
Doxorubicin
2
Dexamethasone
2
Calcium Dobesilate
2
treosulfan
1
pirtobrutinib
1
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Thiotepa
×
30 days
×
Clear all
No trials found.